Gynodaktarin (miconazole nitrate) for vulvovaginal candidiasis.
Rutherford Am
Abstract
Rutherford Am
Abstract
A new potent fungicidal preparation, miconazole nitrate 2 percent (Gynodaktarin) was used in 40 patients, both pregnant, with vulvovaginal candidiasis. It was as effective in pregnant as in non-pregnant patients. Retreatment in three cases of recurrence was successful. There were no side effects reported, and the drug was found to be safe for pregnant patients and their offspring.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A new potent fungicidal preparation, miconazole nitrate 2 percent (Gynodaktarin) was used in 40 patients, both pregnant, with vulvovaginal candidiasis. It was as effective in pregnant as in non-pregnant patients. Retreatment in three cases of recurrence was successful. There were no side effects reported, and the drug was found to be safe for pregnant patients and their offspring.
Key concepts: Miconazole Nitrate, Medicine, Miconazole, Vulvovaginal Candidiasis, Drug, Dermatology, Obstetrics, Antifungal